# HEPARIN SODIUM

NDC: 51662-1409
Generic name: HEPARIN SODIUM
Labeler / Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20191111

FDA application: NDA017029

## Active ingredients

- HEPARIN SODIUM: 10000 [USP'U]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51662-1409"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51662-1409
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=971505d4-f78c-6f5d-e053-2995a90a00e0